Andrew Kuykendall: FDA Approves Rusfertide for Polycythemia Vera
Andrew Kuykendall, Associate Member – Depatment of Malignant Hematology at Moffitt Cancer Center, shared Naveen Pemmaraju‘s post on LinkedIn:
”Such exciting news!
This has been an extremely rewarding process. Thankful to the patients who participated in the studies that led to this approval.
Hearing patients talk about how rusfertide improved their lives provided the energy that got this therapy across the finish line. Happy to have been able to play a role.”
Naveen Pemmaraju, Professor, Department of Leukemia and Executive Director – Cancer Medicine at UT MD Anderson, shared a post on LinkedIn:
”Breaking good news this evening to share! We just found out – Rusfertide (PTG-300) approved. MPNSM Polcythemia Vera
I was proud to co-lead this program from PI standpoint along with Dr Andrew Kuykendall as lead.
I am super proud to see this moment for our patients with PV, and for a brand new class of drug therapies Hepcidin Mimetics to become an option for PV Treatment, and to continue to serve as senior global PI leader for the program.
What a moment for our MPNSM field.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day